Aviva’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Aviva’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-249,093	Closed	-$25.5M	–	853
2014 Q4	$25.5M	Buy	249,093 +2,231	+0.9%	+$214K	0.2%	117
2014 Q3	$21.4M	Sell	246,862 -391	-0.2%	-$34.6K	0.17%	140
2014 Q2	$22.3M	Sell	247,253 -4,731	-2%	-$354K	0.17%	147
2014 Q1	$18.6M	Sell	251,984 -6,989	-3%	-$487K	0.15%	167
2013 Q4	$17.6M	Sell	258,973 -96,810	-27%	-$6.3M	0.15%	175
2013 Q3	$21.7M	Sell	355,783 -23,493	-6%	-$1.43M	0.19%	138
2013 Q2	$21.1M	Buy	+379,276	New	+$21.9M	0.21%	128

Aviva's COV Position: Q1 2015 in Review

Aviva sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 249,093 shares — an estimated $25.5M sold.

Aviva first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $25.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Aviva reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Aviva sold 249,093 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $25.5M.
Aviva first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
Aviva's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $25.5M in Q4 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Aviva's 13F filing for Q1 2015, filed 14 May 2015.